This $199,295 National Science Foundation project grant funded the development of a comparative online simulation tool for COVID-19 vaccine allocation strategies. Funded under the Biological Sciences program (CFDA 47.074), the Fred Hutchinson Cancer Research Center will create a mathematical model of SARS-CoV-2 transmission incorporating multiple vaccines, viral variants, and demographic factors. This model will then be used to develop a free, open-source, online comparative tool allowing up...
The National Science Foundation (NSF) awarded a $448,823 Project Grant under its Social, Behavioral, and Economic Sciences program (CFDA 47.075) to the Trustees of Boston University. This two-year grant, running from September 1, 2023 to August 31, 2025, aims to assess the effectiveness of various health communication tactics employed by federal, state, and local agencies to encourage vaccine uptake. The project will build a database of vaccine messaging from public health agencies, evaluate the...
The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...
This Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), will fund a comprehensive study on the impact of minor vaccine consent (VC) laws on COVID-19 vaccine uptake and transmission among adolescents. The $1,266,296 award, effective from September 16, 2024 to March 10, 2025, will support the University of Pittsburgh's research team in developing a legal...
The U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) awarded a $9.5M project grant under the Extension Collaborative on Immunization Teaching & Engagement (EXCITE) program to the Extension Foundation. This grant, spanning from Sep 2024 to May 2027, aims to stabilize and increase routine immunization rates in rural and underserved communities. The key objectives are to: 1) increase public confidence in adult vaccinations through collaboration with...
This federal Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) to New York University School of Medicine aims to synergize neutralizing and non-neutralizing antibody targets at the HIV/SIV viral spike apex to develop an improved HIV vaccine. The $228,825 award, active from Aug 2024 to Jun 2026, will 1) design and validate a V2B-focused immunogen, and 2) test the combination of vaccine-elicited anti-V2B...
The Department of Health and Human Services Administration for Children and Families awarded Futures Without Violence $3 million under the Family Violence Prevention and Services/Discretionary (CFDA 93.592) cooperative agreement program. The award will support COVID-19 testing, vaccines, and mobile health units from March 2021 through September 2025. The Family Violence Prevention and Services program aims to improve capacity for addressing family violence through resource information, training,...
The National Science Foundation Division of Environmental Biology awarded a $186,835 Project Grant to the University of Southern California Department of Contracts and Grants to support the project "RAPID: FAST COVID-19 SCENARIO PROJECTIONS IN PRESENCE OF VACCINES AND COMPETING VARIANTS" from August 1, 2021 through July 31, 2022. This funding supports research under the Biological Sciences program (CFDA 47.074), which aims to promote advancement in the biological sciences and...
This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (ELC) program (CFDA 93.323) provides $799,904.00 in funding to New York University School of Medicine to establish an ARISE Coordinating and Collaborating Center for the Study of Vaccine Hesitancy and Uptake. The award, with a performance period of September 30, 2024 to September 29, 2029, will support research and coordination...
This federal Project Grant award of $360,000 from the National Science Foundation's (NSF) Division of Mathematical Sciences and the CDC Coronavirus and Other Respiratory Viruses Division aims to improve policymaking processes for mitigating the transmission of respiratory pathogens, such as during the COVID-19 pandemic. The principal investigators will develop and study game theoretical mathematical models, simulation tools, and numerical approaches that can be adapted to specific public...